Correspondence between Pharmac and NZMS
D Smith made this Official Information request to Pharmaceutical Management Agency
This request has an unknown status. We're waiting for D Smith to read recent responses and update the status.
From: D Smith
Dear Pharmaceutical Management Agency,
Under the Offical Information Act, please provide all correspondence (including emails, phone records, meeting minutes and sent from and to NZMS Diabetes or NZMS relating to the Dexcom G6, Dexcom G5, Tandem Tslim X2 insulin pump or the acquisition by Dexcom Inc. received since January 14th 2021.
Please provide all information you hold directly relating to the upcoming meeting of the Diabetes Subcommittee mentioned in this OIA release https://pharmac.govt.nz/about/what-we-do....
Yours faithfully,
D Smith.
From: Web Enquiry
Pharmaceutical Management Agency
Kia ora D Smith
Thank you for your email.
Your request has been received and logged. Our reference number for your
request is: 2021-22-016.
As required under the Official Information Act 1982, we will respond to
your request within 20 working days. You should receive a response on or
before 2 September 2021.
If a large amount of information has been requested, we may need to extend
this date (this is provided for in section 15A of the Act). We will advise
you if such an extension is necessary.
Please feel free to contact us if you require any further assistance.
Ngā mihi
Melody Willis ([1]she/her) | Government Services Advisor
___________________________________________________________________
Te Pātaka Whaioranga | Pharmac | PO Box 10 254 | Level 9, 40 Mercer
Street, Wellington
P: +64 4 460 4990 |[2]www.pharmac.govt.nz
show quoted sections
From: Web Enquiry
Pharmaceutical Management Agency
2021 22 016 2021 08 31 OIA extension letter Correspondence between Pharmac and NZMS information relating to 2021 Diabetes Subcommittee meeting.pdf
117K
Download
View as HTML
Kia ora D Smith
Please find attached an extension letter for your recent OIA request.
Please feel free to contact us if you have any questions about this.
Ngā mihi
Melody Willis ([1]she/her) | Government Services Advisor
show quoted sections
From: Web Enquiry
Pharmaceutical Management Agency
2021 22 016 2021 09 24 OIA response letter Correspondence between Pharmac and NZMS information relating to 2021 Diabetes Subcommittee meeting.pdf
127K
Download
View as HTML
Ahiahi marie D Smith
Please find attached a response to your request for information.
We will be in further contact with you soon.
Ngā mihi
Melody Willis ([1]she/her) | Government Services Advisor
show quoted sections
From: Web Enquiry
Pharmaceutical Management Agency
2021 22 016 2021 10 18 OIA response letter Correspondence between Pharmac and NZMS.pdf
102K
Download
View as HTML
2021 22 016 OIA request documents Correspondence between Pharmac and NZMS.pdf
16.2M
Download
View as HTML
Kia ora D Smith
Further to our email to you on 23 September 2021, please find our final
response with documents for your request attached with this email.
Please feel free to contact us if you have any further enquiries.
Ngā mihi
Melody Willis ([1]she/her) | Government Services Advisor
show quoted sections
Things to do with this request
- Add an annotation (to help the requester or others)
- Download a zip file of all correspondence
Offensive? Unsuitable?
Requests for personal information and vexatious requests are not considered valid requests for Official Information (read more).
If you believe this request is not suitable, you can report it for attention by the site administrators
Report this request
Jai Ganesh left an annotation ()
Sooo Medsafe knew that Ivermectin was a safe and effective treatment but because a pharmaceutical company didn't apply to push it out because it's not profitable, they didn't approve it for use when it would have helped more people than the 'vaccine'...great.
Link to this